Australia markets closed

Arcadia Biosciences Inc (17D.MU)

Munich - Munich Delayed price. Currency in EUR
Add to watchlist
2.9600+0.3400 (+12.98%)
At close: 08:06AM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
5,353
5,330
7,418
6,780
8,034
Cost of revenue
3,432
3,300
6,101
8,708
5,199
Gross profit
1,921
2,030
1,317
-1,928
2,835
Operating expenses
Research development
1,300
1,387
1,509
3,889
7,960
Selling general and administrative
13,626
14,508
15,036
22,938
16,467
Total operating expenses
14,926
15,895
16,545
26,827
24,427
Operating income or loss
-13,005
-13,865
-15,228
-28,755
-21,592
Interest expense
-
-
-
20
47
Total other income/expenses net
6,086
13
4,125
12,643
15,489
Income before tax
-6,377
-13,157
-10,814
-16,132
-6,150
Income tax expense
-
8
14
2
-124
Income from continuing operations
-6,385
-13,165
-10,828
-16,134
-6,026
Net income
-7,020
-13,981
-15,376
-14,660
-4,655
Net income available to common shareholders
-7,020
-13,981
-15,376
-14,660
-4,655
Basic EPS
-15.59
-11.30
-25.65
-27.56
-18.80
Diluted EPS
-15.59
-11.30
-25.65
-27.56
-18.80
Basic average shares
1,065
1,237
599.389
532.016
248.975
Diluted average shares
1,065
1,237
599.389
532.016
248.975